In this episode of the Becker’s Healthcare Podcast, Scott Becker is joined by Jakob Emerson, Associate News Director at Becker’s Healthcare. Jakob discusses two major topics: the significant industry impact of GLP-1 weight loss drugs, including recent organizational decisions and research findings, and the ongoing drama surrounding the recalculation of Medicare Advantage star ratings by CMS, which has major financial implications for health plans.